Overview
Hiroki Sakuma practices practicing medicine in Tokyo, Japan.
Mr. Sakuma is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Reticulohistiocytoma, Histiocytosis, and Adult Soft Tissue Sarcoma.
He is actively involved in clinical research, co-authoring 13 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Hiroki Sakuma
Is Hiroki Sakuma a top-rated expert for Reticulohistiocytoma?
MediFind is an objective health platform that identifies experts based on real-world data. Hiroki Sakuma is classified as an Advanced expert for Reticulohistiocytoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Hiroki Sakuma participate in research or clinical trials?
Yes. Hiroki Sakuma has published 13 articles and abstracts on conditions like Reticulohistiocytoma. You can view a list of Hiroki Sakuma's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- HistiocytosisMr. Sakuma isAdvanced. Learn about Histiocytosis.
- ReticulohistiocytomaMr. Sakuma isAdvanced. Learn about Reticulohistiocytoma.
- Experienced
- Adult Soft Tissue SarcomaMr. Sakuma isExperienced. Learn about Adult Soft Tissue Sarcoma.